ZA85529B - Topical drug release system - Google Patents

Topical drug release system

Info

Publication number
ZA85529B
ZA85529B ZA85529A ZA85529A ZA85529B ZA 85529 B ZA85529 B ZA 85529B ZA 85529 A ZA85529 A ZA 85529A ZA 85529 A ZA85529 A ZA 85529A ZA 85529 B ZA85529 B ZA 85529B
Authority
ZA
South Africa
Prior art keywords
drug
phase
liquid
phases
drug release
Prior art date
Application number
ZA85529A
Other languages
English (en)
Inventor
Adrian Francis Davis
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA85529B publication Critical patent/ZA85529B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Confectionery (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA85529A 1984-01-25 1985-01-23 Topical drug release system ZA85529B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848401965A GB8401965D0 (en) 1984-01-25 1984-01-25 Composition

Publications (1)

Publication Number Publication Date
ZA85529B true ZA85529B (en) 1985-11-27

Family

ID=10555518

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85529A ZA85529B (en) 1984-01-25 1985-01-23 Topical drug release system

Country Status (11)

Country Link
US (1) US4767751A (de)
EP (1) EP0151953B1 (de)
JP (1) JPS60174715A (de)
AT (1) ATE71519T1 (de)
AU (1) AU576344B2 (de)
CA (1) CA1249520A (de)
DE (1) DE3585162D1 (de)
DK (1) DK163799C (de)
GB (1) GB8401965D0 (de)
IE (1) IE57733B1 (de)
ZA (1) ZA85529B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
EP0252459A1 (de) * 1986-07-07 1988-01-13 Schering Corporation Kompartimentiertes transdermales Abgabesystem
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
IN168400B (de) * 1987-01-30 1991-03-23 Colgate Palmolive Co
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US4935225A (en) * 1987-09-11 1990-06-19 Curtis John P Appetite suppresant dentifrice
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
AU668679B2 (en) * 1991-02-18 1996-05-16 Transdermal Technologies Pty Limited Composition for use in transdermal administration
GB9118711D0 (en) * 1991-08-31 1991-10-16 Smithkline Beecham Plc Novel device
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5290541A (en) * 1992-06-18 1994-03-01 The Procter & Gamble Company Methods for making oral compositions
JP2542792B2 (ja) * 1992-11-05 1996-10-09 ベクトン・ディッキンソン・アンド・カンパニー ユ―ザ作動型のイオン導入式装置
US5474761A (en) * 1993-04-08 1995-12-12 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5290542A (en) * 1993-04-08 1994-03-01 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5807569A (en) * 1993-05-27 1998-09-15 Smithkline Beecham P.L.C. Topical composition
JPH08505402A (ja) * 1993-08-06 1996-06-11 ジェイ エムブロ,ウィリアム 粘膜表皮性及び表皮性の痛み、炎症及び感染症の治療方法及び治療用組成物
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
EP1471925A2 (de) * 2001-12-21 2004-11-03 Alcon, Inc. Anorganische nanopartikel zur modifizierung der viskosität und physikalischer eigenschaften von ophthalmischen und ohrenheilkundigen zusammensetzungen
EP1474109B1 (de) * 2001-12-21 2010-08-25 Alcon, Inc. Verwendung von synthetischen anorganischen nanoteilchen als träger für augenmedikamente
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005120487A2 (de) * 2004-06-11 2005-12-22 Egon Tech Präparat zur prophylaxe und therapie von stresszuständen, von funktionellen und organischen störungen des nervensystems und des stoffwechsels
EP2457560A1 (de) 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topische Zusammensetzungen
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
US8114159B2 (en) 2006-11-20 2012-02-14 Depuy Spine, Inc. Anterior spinal vessel protector
ES2541483T3 (es) * 2009-12-16 2015-07-21 Shasun Pharmaceuticals Limited Composición de hidrogel transdérmico de dexibuprofeno
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
MX365427B (es) 2011-05-03 2019-06-03 Aponia Laboratories Inc Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas.
JP6997624B2 (ja) 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス,エルエルシー. 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (de) 2018-11-30 2023-06-07 Viramal Limited Verfahren zur herstellung eines geliermittels, das dadurch erhaltene geliermittel und verwendung dieses geliermittels
EP4308088B1 (de) 2021-11-08 2025-03-12 Weiyong Li Transdermales arzneimittelabgabesystem zur abgabe eines arzneimittels an einen patienten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582207A (en) * 1977-05-16 1981-01-07 Sanol Arznei Schwarz Gmbh Stable isosorbide dinitrate solutions preparation thereof and use thereof
US4140656A (en) * 1977-10-07 1979-02-20 Armour-Dial, Inc. Anhydrous clear gel facial cleanser
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition

Also Published As

Publication number Publication date
ATE71519T1 (de) 1992-02-15
DK30585D0 (da) 1985-01-23
EP0151953A2 (de) 1985-08-21
EP0151953B1 (de) 1992-01-15
GB8401965D0 (en) 1984-02-29
DK30585A (da) 1985-07-26
CA1249520A (en) 1989-01-31
IE850146L (en) 1985-07-25
JPH0430923B2 (de) 1992-05-25
JPS60174715A (ja) 1985-09-09
AU3800885A (en) 1985-08-01
IE57733B1 (en) 1993-04-07
DK163799C (da) 1992-08-31
EP0151953A3 (en) 1987-01-21
DK163799B (da) 1992-04-06
AU576344B2 (en) 1988-08-25
DE3585162D1 (de) 1992-02-27
US4767751A (en) 1988-08-30

Similar Documents

Publication Publication Date Title
EP0151953A3 (en) Topical drug release system
EP0289342A3 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
ATE95057T1 (de) Oertliches arzneimittel mit verzoegerter wirkstoffabgabe.
MY101570A (en) Novel pharmaceutical compositions for topical application with systemic action
IL82192A (en) System for administration of drugs to the skin and process for the preparation thereof
EP0023359A3 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
EP0224981A3 (de) Transdermales Einbringungssystem für Nitroglycerin
ATE163654T1 (de) Überkritische flüssigkeitsextraktion mit hydrofluoralkanen
EP0272045A3 (en) Topical drug release system
EP0195605A3 (en) Process of making gelled cellulose triacetate product and a product made thereby
Eymontt et al. The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroid administration
SE8703971D0 (sv) Losliga och/eller sonderdelbara tabletter och sett att framstella dessa
FI843609A7 (fi) Nestemäiset, ionisia aineosia sisältävät farmaseuttiset valmisteet, jotka pidentävät lääkeaineen vapautumista.
KR910021238A (ko) 켈로이드 치료제
ES8701490A1 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
Mizuno Differences of gastric cancers between the greater and the lesser curvature Part III. On the differences of the ribose nucleic acid content of the cancer cells between the greater and the lesser curvatures
Cheng et al. Intrauterine injection of 20 per cent saline for inducing abortion
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
ES2002917A6 (es) Procedimiento para la preparacion de farmacos dermoactivos